| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Brooklyn ImmunoTherapeutics, Inc. Common Stock (NASDAQ: BTX)
BTX Technical Analysis
5
| As on 25th Nov 2022 BTX STOCK Price closed @ 3.30 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7.25 & Strong Sell for SHORT-TERM with Stoploss of 13.38 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BTXSTOCK Price
| Open | 3.22 | Change | Price | % |
| High | 3.38 | 1 Day | 0.16 | 5.13 |
| Low | 3.20 | 1 Week | -0.32 | -8.89 |
| Close | 3.30 | 1 Month | 3.07 | 1461.90 |
| Volume | 2130 | 1 Year | -12.25 | -78.88 |
| 52 Week High 21.35 | 52 Week Low 0.21 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| BTX Daily Charts |
BTX Intraday Charts |
Whats New @ Bazaartrend |
BTX Free Analysis |
|
|
BTX Important Levels Intraday
| RESISTANCE | 4.05 |
| RESISTANCE | 3.80 |
| RESISTANCE | 3.65 |
| RESISTANCE | 3.50 |
| SUPPORT | 3.06 |
| SUPPORT | 2.91 |
| SUPPORT | 2.76 |
| SUPPORT | 2.51 |
BTX Forecast May 2024
| 4th UP Forecast | 30.22 |
| 3rd UP Forecast | 21.58 |
| 2nd UP Forecast | 16.24 |
| 1st UP Forecast | 10.9 |
| 1st DOWN Forecast | -4.34 |
| 2nd DOWN Forecast | -9.68 |
| 3rd DOWN Forecast | -15.02 |
| 4th DOWN Forecast | -23.66 |
BTX Weekly Forecast
| 4th UP Forecast | 9.52 |
| 3rd UP Forecast | 7.52 |
| 2nd UP Forecast | 6.28 |
| 1st UP Forecast | 5.05 |
| 1st DOWN Forecast | 1.51 |
| 2nd DOWN Forecast | 0.28 |
| 3rd DOWN Forecast | -0.96 |
| 4th DOWN Forecast | -2.96 |
BTX Forecast2024
| 4th UP Forecast | 47.87 |
| 3rd UP Forecast | 33.57 |
| 2nd UP Forecast | 24.73 |
| 1st UP Forecast | 15.89 |
| 1st DOWN Forecast | -9.33 |
| 2nd DOWN Forecast | -18.17 |
| 3rd DOWN Forecast | -27.01 |
| 4th DOWN Forecast | -41.31 |
Brooklyn ImmunoTherapeutics, Inc. Common Stock ( NASDAQ USA Symbol : BTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BTX Business Profile
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company is based in Brooklyn, New York. Address: Building A, Brooklyn, NY, United States, 11220
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service